Clinical trials
Phase 2 Kidney Diseases trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2019 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AMAG Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| Janssen Research & Development, LLC | 1 |
| Novo Nordisk A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 4 |
| Renal Insufficiency, Chronic | 2 |
| Anemia | 1 |
| Anemia, Iron-Deficiency | 1 |
| Genetic Diseases, Inborn | 1 |
| Glomerulonephritis | 1 |
| Hyperoxaluria, Primary | 1 |
| Iron Deficiencies | 1 |
| Lupus Nephritis | 1 |
| Proteinuria | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.